New blood test could end painful liver biopsies for millions
NCT ID NCT04616664
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new blood test called LLIFT to see if it can accurately diagnose fatty liver disease and its severe form, NASH, without needing a liver biopsy. Researchers enrolled 158 people at high risk for metabolic syndrome. The LLIFT test combines patient information like age, weight, and diabetes status with blood markers and genetic data. If proven accurate, this test could make screening for liver disease much easier and safer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LLIFT (Lille LIver Fat Test) – a blood test combining clinical data, lab values, and genetic markers
What this could lead to
If successful, this could provide a simple, non-invasive blood test to diagnose fatty liver disease and NASH, replacing the need for a liver biopsy in many patients.
What could go wrong
This is a diagnostic accuracy study, not a treatment trial. The test may not be accurate enough to replace biopsy in all cases, and results may not apply to lower-risk populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH ARRAS
Arras, France
-
CH LENS
Lens, France
-
CH de Douai
Douai, France
-
Ch Valenciennes
Valenciennes, France
-
Chu Amiens Picardie
Amiens, France
-
GHIRCL saint Philibert
Lomme, France
-
Hop Claude Huriez Chu Lille
Lille, 59037, France